Amicus Therapeutics, Inc.

BMV:FOLD * 株式レポート

時価総額:Mex$58.4b

Amicus Therapeutics 将来の成長

Future 基準チェック /56

Amicus Therapeutics is forecast to grow earnings and revenue by 61.4% and 24.3% per annum respectively while EPS is expected to grow by 59% per annum.

主要情報

61.4%

収益成長率

59.0%

EPS成長率

Biotechs 収益成長0%
収益成長率24.3%
将来の株主資本利益率n/a
アナリストカバレッジ

Good

最終更新日24 Apr 2023

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

BMV:FOLD * - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20257501831751666
12/31/202456460658811
12/31/2023393-111-69-6612
12/31/2022329-237-170-167N/A
9/30/2022323-264-159-156N/A
6/30/2022321-281-172-168N/A
3/31/2022318-270-192-188N/A
12/31/2021306-250-206-202N/A
9/30/2021294-239-185-182N/A
6/30/2021282-252-203-200N/A
3/31/2021267-254-201-198N/A
12/31/2020261-277-237-233N/A
9/30/2020246-295-254-241N/A
6/30/2020227-293-272-255N/A
3/31/2020209-325-298-280N/A
12/31/2019182-356-270-250N/A
9/30/2019160-345-264-253N/A
6/30/2019131-442-340-330N/A
3/31/2019109-419-337-329N/A
12/31/201891-349-306-300N/A
9/30/201873-340-318-312N/A
6/30/201864-293-233-228N/A
3/31/201849-279-218-213N/A
12/31/201737-284-218-214N/A
9/30/201725-273-176-173N/A
6/30/201716-208-168-165N/A
3/31/20179-211-159-155N/A
12/31/20165-200-156-150N/A
9/30/20162-184N/A-154N/A

アナリストによる今後の成長予測

収入対貯蓄率: FOLD * is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (7.5%).

収益対市場: FOLD * is forecast to become profitable over the next 3 years, which is considered above average market growth.

高成長収益: FOLD * is expected to become profitable in the next 3 years.

収益対市場: FOLD *'s revenue (24.3% per year) is forecast to grow faster than the MX market (6.2% per year).

高い収益成長: FOLD *'s revenue (24.3% per year) is forecast to grow faster than 20% per year.


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: Insufficient data to determine if FOLD *'s Return on Equity is forecast to be high in 3 years time


成長企業の発掘